Placenta, Umbilical Cord, and Umbilical Cord Blood as a Source of Therapeutic Cells


About this study

The purpose of this study is to collect, isolate and culture progenitor cells.  To determine optimal methods for isolation, culture, transfection, and differentiation of these cells with potential therapeutic uses.  To act as a central resource for the investigation of these cells for researchers at the Mayo Clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients age 18 and older in their second or third trimester of normal pregnancy will be eligible to participate in this research study.  

Exclusion Criteria: 

  • Abnormal pregnancy that may include birth defects of the fetus, maternal complications with the placenta or umbilical cord anatomy, and/or any complications during the birthing process

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Allan Dietz, Ph.D.

Open for enrollment

Contact information:

Myra Wick M.D., Ph.D.

(507) 284-9482

More information


Publications are currently not available

Mayo Clinic Footer